A shape-memory alloy orthopedic implant includes a bridge having a curved longitudinal axis, a first end, and a second end opposite the first end. The bridge has a radially outer surface extending axially from the first end to the second end. In addition, the orthopedic implant includes a first leg extending from the first end of the bridge. The first leg has a central axis, a fixed end fixably attached to the bridge, a free end distal the bridge, and a radially outer surface extending axially from the fixed end of the first leg to the free end of the first leg. Further, the orthopedic implant includes a second leg extending from the second end of the bridge. The second leg has a central axis, a fixed end fixably attached to the bridge, a free end distal the bridge, and a radially outer surface extending axially from the fixed end of the second leg to the free end of the second leg. The radially outer surface of the bridge defines a first outer profile in a cross-section of the bridge taken in a plane oriented perpendicular to the longitudinal axis of the bridge. The radially outer surface of the first leg defines a second outer profile in a cross-section of the first leg taken in a plane oriented perpendicular to the central axis of the first leg. The first outer profile has a different geometry than the second outer profile.

Described herein are devices, systems and methods for treating disease and/or infection by the release of silver from an implant over an extended period of time. In particular, the devices described herein may be used to treat infections such as osteomyelitis by the controlled release of silver ions from multiple sites of an extended-use implant. This implant typically includes a plurality of arms that both anchor and help distribute the released ions within the tissue. Power may be applied to release the silver ions into the tissue.

The present disclosure relates to implantable encapsulation devices for housing a biological moiety or a therapeutic device that contains a biological moiety. Particularly, aspects of the present disclosure are directed to an implantable apparatus that includes a distal end, a proximal end, a manifold including at least one access port positioned either at the distal end or the proximal end, and a plurality of containment tubes affixed to the manifold and in fluid communication with the at least one access port. Additionally, the encapsulation device may contain a flush port and a tube that are fluidly connected to the manifold. The containment tubes may contain therein a biological moiety (e.g., cells) or a therapeutic device (e.g. a cell encapsulation member).

An embodiment includes individual SMP foams that radially expand and fill gaps around a heart valve that may be improperly seated, in an unusual cross section, or has poor apposition against a calcified lesion. Other embodiments are described herein.

An implantable object (1000′) and a method (100) of fabricating an implantable object is disclosed. The method (100) comprises melting a powder (210) comprising at least nickel and titanium with an energy source (220) and iteratively forming a plurality of stacked metallic layers (330) from the melted powder using an additive manufacturing technique. The implantable object is biased to expand from a first configuration (501) to a second configuration (502) when at or above a transformation temperature.

Example medical devices and methods of making example medical devices are disclosed. An example medical device includes a frame configured to be secured to cardiac tissue, wherein the frame includes a fatigue resistant nickel-titanium alloy that is heat set at a temp in the range of 450-550 degrees Celsius.

This invention relates to the design and function of a compressible valve replacement prosthesis, collared or uncollared, which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed focuses on the deployment of a device via a minimally invasive fashion and by way of example considers a minimally invasive surgical procedure preferably utilizing the intercostal or subxyphoid space for valve introduction. In order to accomplish this, the valve is formed in such a manner that it can be compressed to fit within a delivery system and secondarily ejected from the delivery system into the annulus of a target valve such as a mitral valve or tricuspid valve.

The present invention relates to a perfusion balloon catheter that has an expandable (enlargeable) inner lumen (114) with a novel design feature that allows a continuous flow through this enlarged lumen sufficient perfusion to the distal lumen of the blood vessel or air passage concurrent to and independently of balloon (104) inflation or deflation resulting in the prolonged dilatation and avoiding the high risks of blood or air flow stricture during balloon inflation.

Proposed is a nitinol nanofiber with an average surface roughness that is enhanced through mechanical and chemical treatments. The enhanced surface roughness improves biocompatibility and promotes tissue growing, thereby improving the bioavailability of the nitinol nanofiber. The nitinol nanofiber undergoes infrared irradiation whereby the nitinol fiber exhibits improved tensile strength, elastic modulus, and maximum restorative stress. Therefore, fatigue fraction does not easily occur in the nitinol fiber even when the nitinol nanofiber has a constant roughness. The present invention provides bio-use or medical nitinol nanofibers that are highly biocompatible.

Devices, systems, and methods for combinatorial treatment of a condition with an implantable damping device and therapeutic agent (e.g., drug) are disclosed herein. Methods for treating one or more effects of the condition, such as a neurological condition, include providing the implantable damping device and at least neck one other therapy, such as a therapeutic agent, that treats the condition to the patient. The implantable damping device includes a flexible damping member and an abating substance and can be placed in apposition with a blood vessel. The flexible damping member forms a generally tubular structure having an inner and an outer surface, the inner surface formed of a sidewall having a partially deformable portion. The abating substance is disposed within the partially deformable portion and moves longitudinally and/or radially within the partially deformable portion in response to pulsatile blood flow.